ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1859

Joint Tenderness and Ultrasound Inflammation in DMARD-naïve Early Rheumatoid Arthritis Patients

Nina Sundlisater1, Anna-Birgitte Aga 2, Hilde Hammer 1, Till Uhlig 3, Tore Kvien 3, Espen Haavardsholm 3 and Siri Lillegraven 4, 1Diakonhjemmet Hospital, Department of Rheumatology, Oslo, Norway, 2Diakonhjemmet Hospital, Department of Rheumatology, Oslo, Oslo, Norway, 3Diakonhjemmet Hospital, Dept. of Rheumatology / University of Oslo, Faculty of Medicine, Oslo, Norway, 4Diakonhjemmet Hospital, Dept. of Rheumatology, Oslo, Norway

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: Disease Activity and ultrasonography, Early Rheumatoid Arthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 11, 2019

Title: 4M111: Imaging of Rheumatic Diseases I (1854–1859)

Session Type: ACR Abstract Session

Session Time: 4:30PM-6:00PM

Background/Purpose: A tender joint count is part of most disease activity scores and remission criteria in rheumatoid arthritis (RA). A recent study in established RA found that tender joint count might not reflect inflammatory activity assessed by ultrasound (1). Our objective was to explore if tender non-swollen joints is associated with subclinical inflammation, assessed by ultrasound, in DMARD-naïve early RA patients.

Methods: DMARD-naïve RA patients with < 2 years symptom duration from first swollen joint and indication for DMARD treatment were included in the ARCTIC trial (2). For the current analyses we used data from the baseline examination, including a tender joint count assessed by Ritchie Articular Index and a 44-swollen joint count. The Ritchie Articular Index treat certain joints as a single unit (as the MCP-joints), and scoring of tenderness in joints and joint groups is graded 0-3. All patients underwent an ultrasound examination of 32 joints, with a semi-quantitative 0-3 score for power Doppler in each joint. An ultrasound atlas was available for reference (3). We predefined the wrist and the MCP 1-5 joints as joint areas of interest since they are commonly involved in RA and were assessed both clinically and by ultrasound. We selected only joints that were clinically non-swollen, and assessed the association between joint tenderness and ultrasound power Doppler signal by mixed logistic regression models with patient-specific intercept to adjust for within-patient dependencies. The analyses were repeated using generalized estimating equations for robustness. The frequency and odds ratio (OR) of ultrasound power Doppler activity (yes/no) in tender non-swollen wrists compared to non-tender non-swollen wrists were calculated. Similar analyses were performed for the MCP joints.

Results: A total of 222 patients with complete baseline data were included. 63% were female, median [IQR] age was 53.6 [41.2, 62.3] years, symptom duration 5.8 [2.9, 10.4] months, swollen joint count 9 [4, 15], joint tenderness 7 [4, 13] and power Doppler score 7 [3, 14]. Of 444 wrists, 268 were not swollen. The frequency of power Doppler signal >0 in tender non-swollen wrists were 50% (18/36), compared to 23% (53/232) in non-tender non-swollen wrists (p-value for comparison = 0.001). This corresponds to an OR of 4.32 (95% CI 1.47 to 12.65, p=0.008) for power Doppler signal if the wrist was tender but not swollen, compared to a non-tender non-swollen wrist. Similar results were found for the non-swollen MCP-joints (Table).

 

Table: The frequency and odds ratio (OR) of ultrasound power Doppler (PD) activity in Ritchie positive versus Ritchie negative non-swollen wrists and MCP joints.

 

PD-signal positive if Ritchie positive

PD-signal positive if Ritchie negative

OR (CI)

p-value

Non-swollen wrist, n=268

18/36 (50%)

53/232 (23%)

4.32 (1.47 to 12.65)

0.008

Non-swollen MCP joints, n=165

15/35 (43%)

28/130 (22%)

4.84 (1.31 to 17.89)

0.02

 

Conclusion: Ultrasound power Doppler activity was more frequent in non-swollen wrists and non-swollen MCP joints if the joints had been scored as tender or painful by Ritchie Articular Index. Our findings indicate that in early RA patients, tenderness might reflect inflammation which is not detectable clinically.


Disclosure: N. Sundlisater, None; A. Aga, AbbVie, 2, 8, Eli Lilly, 8, MSD, 2, Norwegian Research Council, 2, Norwegian Rheumatism Association, 2, Norwegian South-Eastern Health Region, 2, Norwegian Women's Public Health Association, 2, Novartis, 8, Pfizer, 2, 8, Roche, 2, UCB, 2, 8; H. Hammer, None; T. Uhlig, None; T. Kvien, AbbVie, 2, 8, Biogen, 5, 8, Biogen, Egis, Eli Lilly, Hikma, Mylan, Novartis/Sandoz, Oktal, Hospira/Pfizer, Sanofi and UCB, 5, BMS, 8, Celltrion, 8, Egis, 5, 8, Eli Lilly, 5, 8, Hikma, 5, 8, Hospira/Pfizer, 2, 5, 8, MSD, 2, 8, Mylan, 5, 8, Novartis, 8, Novartis/Sandoz, 5, 8, Oktal, 5, 8, Orion Pharma, 8, Roche, 2, 8, Sandoz, 8, Sanofi, 5, 8, UCB, 5, 8; E. Haavardsholm, AbbVie, 2, 8, Cellgene, 8, Eli Lilly, 8, Janssen, 8, MSD, 2, Norwegian Research Council, 2, Norwegian South-Eastern Health Region, 2, Pfizer, 2, 8, Roche, 2, UCB, 2, 8; S. Lillegraven, AbbVie, 2, MSD, 2, Norwegian Research Council, 2, Norwegian South-Eastern Health Region, 2, Pfizer, 2, Roche, 2, UCB, 2.

To cite this abstract in AMA style:

Sundlisater N, Aga A, Hammer H, Uhlig T, Kvien T, Haavardsholm E, Lillegraven S. Joint Tenderness and Ultrasound Inflammation in DMARD-naïve Early Rheumatoid Arthritis Patients [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/joint-tenderness-and-ultrasound-inflammation-in-dmard-naive-early-rheumatoid-arthritis-patients/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/joint-tenderness-and-ultrasound-inflammation-in-dmard-naive-early-rheumatoid-arthritis-patients/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology